Reprint

New Perspectives on Cardiovascular Disease: Women's Treatment and Management

Edited by
April 2024
136 pages
  • ISBN978-3-7258-0735-2 (Hardback)
  • ISBN978-3-7258-0736-9 (PDF)

This book is a reprint of the Special Issue New Perspectives on Cardiovascular Disease: Women's Treatment and Management that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality in women, despite the overall reduction in age-adjusted CVD mortality within recent years. Aside from the traditional risk factors and predictors of increased CVD risks in both sexes, there are also RFs specific to women. These relate to their reproductive and gynecological history. Moreover, among women, there is a lack of knowledge and perception regarding CVD. When compared to men, women with CVD are typically underdiagnosed and undertreated. The problem is more significant among women due to the incorrect and ingrained belief that CVD is primarily, if not exclusively, a male disease. This misunderstanding originates from the perceived differences in the clinical presentation of CVD across the two sexes, as well as from the increased prevalence of advanced postmenopausal symptoms in women. The aim of this Special Issue was to gather new data concerning the peculiar features of CVD and risk factors in women, with the aim of reducing the underestimation of CVD risk. There is also great focus on strategies for prevention, management, and therapy, specifically pertaining to women’s needs. 

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
awareness; cardiovascular disease; cardiovascular risk factors; knowledge; perception; women; infective endocarditis; sex-specific; gender; risk factors; survival; infective endocarditis; sex; heart valve surgery; comorbidities; in-hospital mortality; aging; women; nutrients; physical activity; long COVID; monitoring; vital signs; Lp(a); biomarkers; mortality; non-fatal myocardial infarction; coronary artery disease; prognosis; sex-related differences; residual risk; type 2 diabetes; acute coronary syndrome; sex-differences; healthcare; public health; real-world; physical inactivity; physical activity; cardiovascular risk; women; gender medicine; myocardial repolarization; Tend; sex differences; chronic heart failure telemonitoring; risk factors; myocardial infarction; sex; gender; women; acute heart failure; gender medicine; pharmacological treatments; prognosis